TrialAnnals of the rheumatic diseases2017

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).

Thomas Bardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.